Last updated: February 19, 2024
Sponsor: Centre Hospitalier Universitaire Dijon
Overall Status: Active - Recruiting
Phase
N/A
Condition
White Cell Disorders
Immune (Idiopathic) Thrombocytopenic Purpura (Itp)
Thrombosis
Treatment
spleen sample
blood sample
Clinical Study ID
NCT02821572
BONNOTTE PARI 2013
Ages > 18 All Genders Accepts Healthy Volunteers
Study Summary
Eligibility Criteria
Inclusion
Inclusion Criteria: ITP group
- Patients who have provided written consent
- Patients over 18 years
- Patients with national health insurance
- Patients with ITP, defined as thrombocytopenia < 100 G/L, after exclusion ofinfection- or drug-related thrombocytopenia and malignant hemopathy. Control Group
- Persons who have provided a written consent
- Persons over 18 years
- Persons with national health insurance
- Persons without autoimmune disease
Exclusion
Exclusion Criteria:
- Patients under guardianship
- Pregnancy
Study Design
Total Participants: 70
Treatment Group(s): 2
Primary Treatment: spleen sample
Phase:
Study Start date:
October 02, 2014
Estimated Completion Date:
September 30, 2024
Connect with a study center
CHU Dijon Bourgogne
Dijon, 21079
FranceActive - Recruiting

Not the study for you?
Let us help you find the best match. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.